AR
ARDT
Ardent Health, Inc.
$9.35
-3.31%
$1.3B
No data for this timeframe.
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Analyst ConsensusBuy (67%)
Inst. Holders50 funds
Inst. Value$86.2M
Inst. Activity10 buys / 5 sells
Insider Activity2B / 0S
Insider Net $$186.4K
SEC Reports5
Exchange NYSE·Sector Services-General Medical & Surgical Hospitals, NEC·Inc. DE·CIK 0001756655·Prev Close $9.67
Recent Activity
Jun 11, 2026
SEC
Three mega-passive institutional investors (Vanguard, BlackRock, Morgan Stanley) added to their ARDT positions in Q3 202
INST-CLUSTER — Impact 3/10
Jun 5, 2026
Insider
LUMSDAINE ALFRED bought 10,000 shares
Chief Financial Officer @ $8.81 ($88.1K)
Jun 5, 2026
Insider
DeMichiei Robert bought 11,260 shares
Director @ $8.73 ($98.3K)
Jun 2, 2026
SEC
Ardent Health appointed COO Dave Caspers as President and CEO, succeeding Marty Bonick who stepped down effective June 2
8-K — Impact 5/10
May 5, 2026
SEC
Ardent Health reported Q1 2026 revenue of $1.602B (+7% YoY) and adjusted EBITDA of $124M (+26.3%), with GAAP diluted EPS
8-K — Impact 6/10
Apr 1, 2026
Insider
Byers David Raynor was granted 11,538 shares
SVP & Chief Accounting Officer
Inst.
AMERIPRISE FINANCIAL INC — ADD
1,776,726 shares ($15.2M)
Inst.
FIRST TRUST ADVISORS LP — ADD
478,795 shares ($4.1M)
Price Targets
$12.41
+32.7% upside
Strong Buy
Current $9.35
Low $9.00
Median $13.00
High $14.00
11 analysts
$9.00
$14.00
Analyst Ratings
5Strong Buy
7Buy
5Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 7, 2026 | UBS | MAINTAIN | Buy → Buy |
| Mar 10, 2026 | RBC Capital | MAINTAIN | Outperform → Outperform |
| Mar 6, 2026 | Leerink Partners | MAINTAIN | Outperform → Outperform |
| Jan 20, 2026 | JP Morgan | MAINTAIN | Neutral → Neutral |
| Dec 18, 2025 | UBS | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.26 | $0.21 — $0.32 | -53% YoY | 4 |
| Next Q | $0.25 | $0.16 — $0.34 | -70% YoY | 4 |
| Current FY | $1.32 ▲ +2.7% | $1.09 — $1.56 | -14% YoY | 2 |
| Next FY | $1.32 | $1.10 — $1.62 | -0% YoY | 4 |
Latest Reports
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional investors (Vanguard, BlackRock, Morgan Stanley) added to their ARDT positions in Q3 202
Jun 11, 2026
MIXED
8-K
5/10
Ardent Health appointed COO Dave Caspers as President and CEO, succeeding Marty Bonick who stepped down effective June 2
Jun 2, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| AMERIPRISE FINANCIAL INC | $15.2M | ADD |
| BlackRock, Inc. | $15.1M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.6M | — |
| ExodusPoint Capital Management, LP | $5.6M | — |
| STATE STREET CORP | $5.0M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 5, 2026 | LUMSDAINE ALFRED | BUY | $88.1K |
| Jun 5, 2026 | DeMichiei Robert | BUY | $98.3K |
| Apr 1, 2026 | Byers David | A | $0.00 |
| Apr 1, 2026 | Petrovich Stephen | F | $15.7K |
| Apr 1, 2026 | Bonick Martin | F | $95.0K |
50 institutional holders with $86.2M total value (10,074,832 shares) as of 2026-Q1. Top holders: AMERIPRISE, BlackRock,, VANGUARD. Net buying activity: 10 institutions added/increased vs 5 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | AMERIPRISE FINANCIAL INC | 1,776,726 | $15.2M | 17.6% | ADD +58.4% |
| 2 | BlackRock, Inc. | 1,758,215 | $15.1M | 17.5% | ADD +27.1% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1,008,438 | $8.6M | 10.0% | — |
| 4 | ExodusPoint Capital Management, LP | 657,903 | $5.6M | 6.5% | — |
| 5 | STATE STREET CORP | 586,058 | $5.0M | 5.8% | — |
| 6 | FIRST TRUST ADVISORS LP | 478,795 | $4.1M | 4.8% | ADD +70.9% |
| 7 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 442,596 | $3.8M | 4.4% | — |
| 8 | BANK OF AMERICA CORP /DE/ | 361,038 | $3.1M | 3.6% | — |
| 9 | MORGAN STANLEY | 292,031 | $2.5M | 2.9% | TRIM -59.9% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 279,616 | $2.4M | 2.8% | — |
| 11 | TWO SIGMA INVESTMENTS, LP | 246,307 | $2.1M | 2.4% | — |
| 12 | GOLDMAN SACHS GROUP INC | 219,011 | $1.9M | 2.2% | — |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 195,571 | $1.7M | 1.9% | DOUBLED +246.1% |
| 14 | CITADEL ADVISORS LLC | 168,921 | $1.4M | 1.7% | — |
| 15 | Vanguard Global Advisers, LLC | 161,589 | $1.4M | 1.6% | — |
| 16 | STATE OF WISCONSIN INVESTMENT BOARD | 158,676 | $1.4M | 1.6% | ADD +61.6% |
| 17 | VANGUARD FIDUCIARY TRUST CO | 151,789 | $1.3M | 1.5% | — |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 121,374 | $1.0M | 1.2% | DOUBLED +159.9% |
| 19 | D. E. Shaw & Co., Inc. | 83,714 | $716.6K | 0.8% | — |
| 20 | Invesco Ltd. | 73,825 | $631.9K | 0.7% | ADD +84.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | ADD | 1,121,557 | 1,776,726 | +58.4% | $15.2M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | ADD | 280,200 | 478,795 | +70.9% | $4.1M | 2026-Q1 |
| MORGAN STANLEY | TRIM | 727,369 | 292,031 | -59.9% | $2.5M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 46,699 | 121,374 | +159.9% | $1.0M | 2026-Q1 |
| Nuveen, LLC | DOUBLED | 30,686 | 68,300 | +122.6% | $584.6K | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 155,984 | 39,976 | -74.4% | $342.2K | 2026-Q1 |
| Russell Investments Group, Ltd. | DOUBLED | 1,920 | 27,182 | +1315.7% | $232.7K | 2026-Q1 |
| Mariner, LLC | DOUBLED | 11,098 | 26,840 | +141.8% | $229.7K | 2026-Q1 |
| Legal & General Group Plc | TRIM | 27,017 | 18,389 | -31.9% | $157.4K | 2026-Q1 |
| CWM, LLC | DOUBLED | 6,708 | 17,902 | +166.9% | $153.2K | 2026-Q1 |
| Brevan Howard Capital Management LP | TRIM | 27,838 | 10,898 | -60.9% | $93.3K | 2026-Q1 |
| FMR LLC | DOUBLED | 1,073 | 10,379 | +867.3% | $88.8K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 385 | 1,238 | +221.6% | $10.6K | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | DOUBLED | 571 | 1,151 | +101.6% | $9.9K | 2026-Q1 |
| DEUTSCHE BANK AG\ | NEAR_EXIT | 15,211 | 56 | -99.6% | $479.00 | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | TRIM | 1,769,335 | 1,121,557 | -36.6% | $9.9M | 2025-Q4 |
| MORGAN STANLEY | ADD | 581,442 | 727,369 | +25.1% | $6.4M | 2025-Q4 |
| FIRST TRUST ADVISORS LP | ADD | 201,250 | 280,200 | +39.2% | $2.5M | 2025-Q4 |
| STATE OF WISCONSIN INVESTMENT BOARD | ADD | 84,830 | 137,124 | +61.6% | $1.2M | 2025-Q4 |
| STRS OHIO | ADD | 42,400 | 62,400 | +47.2% | $551.0K | 2025-Q4 |
| Verition Fund Management LLC | TRIM | 85,561 | 44,653 | -47.8% | $394.3K | 2025-Q4 |
| Nuveen, LLC | NEAR_EXIT | 325,479 | 30,686 | -90.6% | $271.0K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 20,105 | 25,963 | +29.1% | $229.3K | 2025-Q4 |
| Point72 Asset Management, L.P. | NEAR_EXIT | 108,750 | 13,165 | -87.9% | $116.2K | 2025-Q4 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | DOUBLED | 4,600 | 10,400 | +126.1% | $91.8K | 2025-Q4 |
16 unique insiders with 31 transactions. Net insider value: $186.4K ($186.4K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | LUMSDAINE ALFRED | Chief Financial Officer | BUY | 10,000 | $8.81 | $88.1K |
| Jun 5, 2026 | DeMichiei Robert | Director | BUY | 11,260 | $8.73 | $98.3K |
| Apr 1, 2026 | Byers David Raynor | SVP & Chief Accounting Officer | AWARD | 11,538 | — | — |
| Apr 1, 2026 | Petrovich Stephen C. | EVP, GC and Secretary | TAX W/H | 1,808 | $8.67 | $15.7K |
| Apr 1, 2026 | Bonick Martin | President and CEO | TAX W/H | 10,952 | $8.67 | $95.0K |
| Apr 1, 2026 | Caspers Dave | Chief Operating Officer | TAX W/H | 2,684 | $8.67 | $23.3K |
| Apr 1, 2026 | Bonick Martin | President and CEO | AWARD | 134,615 | — | — |
| Apr 1, 2026 | LUMSDAINE ALFRED | Chief Financial Officer | AWARD | 53,846 | — | — |
| Apr 1, 2026 | LUMSDAINE ALFRED | Chief Financial Officer | TAX W/H | 4,381 | $8.67 | $38.0K |
| Apr 1, 2026 | Byers David Raynor | SVP & Chief Accounting Officer | TAX W/H | 924 | $8.67 | $8.0K |
| Apr 1, 2026 | Petrovich Stephen C. | EVP, GC and Secretary | AWARD | 24,904 | — | — |
| Apr 1, 2026 | Caspers Dave | Chief Operating Officer | AWARD | 35,673 | — | — |
| Apr 1, 2026 | BYNOE PETER C B | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Campion Suzanne | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | GOODYEAR WILLIAM M | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Sen Rahul | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | DeMichiei Robert | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Bulgarelli Peter J. | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Robinson Edmondo | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Webb Robert Thomas | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Sotir Mark R | Director | AWARD | 14,231 | — | — |
| Apr 1, 2026 | Havdala Ellen | Director | AWARD | 14,231 | — | — |
| Mar 31, 2026 | LUMSDAINE ALFRED | Chief Financial Officer | TAX W/H | 2,510 | $8.56 | $21.5K |
| Mar 31, 2026 | Petrovich Stephen C. | EVP, GC and Secretary | TAX W/H | 1,425 | $8.56 | $12.2K |
| Mar 31, 2026 | Bonick Martin | President and CEO | TAX W/H | 8,026 | $8.56 | $68.7K |
| Mar 31, 2026 | Byers David Raynor | SVP & Chief Accounting Officer | TAX W/H | 819 | $8.56 | $7.0K |
| Mar 11, 2026 | Chernin Ethan | President of Health Services | AWARD | 32,408 | — | — |
| Mar 11, 2026 | Bonick Martin | President and CEO | AWARD | 195,316 | — | — |
| Mar 11, 2026 | LUMSDAINE ALFRED | Chief Financial Officer | AWARD | 61,081 | — | — |
| Mar 11, 2026 | Byers David Raynor | SVP & Chief Accounting Officer | AWARD | 8,859 | — | — |
| Mar 11, 2026 | Petrovich Stephen C. | EVP, GC and Secretary | AWARD | 34,733 | — | — |
5 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 2 mixed, 2 neutral. Avg impact: 4.4/10.
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional investors (Vanguard, BlackRock, Morgan Stanley) added to their ARDT
Jun 11, 2026
MIXED
8-K
5/10
Ardent Health appointed COO Dave Caspers as President and CEO, succeeding Marty Bonick who stepped d
Jun 2, 2026
BULLISH
8-K
6/10
Ardent Health reported Q1 2026 revenue of $1.602B (+7% YoY) and adjusted EBITDA of $124M (+26.3%), w
May 5, 2026
NEUTRAL
DEFA14A
2/10
Ardent Health's 2026 proxy filing is routine, with no material changes or activist involvement. The
Apr 8, 2026
MIXED
8-K
6/10
Ardent Health reported mixed Q4 2025 results with flat revenue and a 61% YoY decline in net income,
Mar 4, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 18 analysts: 5 strong buy, 7 buy, 5 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$12.41 mean target
+32.7% upside
Strong Buy (2.00)
$9.00 Low
$14.00 High
| Metric | Value |
|---|---|
| Current Price | $9.35 |
| Target Low | $9.00 |
| Target Mean | $12.41 |
| Target Median | $13.00 |
| Target High | $14.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.26 | $0.21 | $0.32 | -52.8% | +0.0% | 0↑ 3↓ | $1.6B | -0.1% | 4 |
| Next Q 2026-09-30 |
$0.25 | $0.16 | $0.34 | -69.9% | +0.0% | 1↑ 2↓ | $1.6B | 3.9% | 4 |
| Current FY 2026-12-31 |
$1.32 | $1.09 | $1.56 | -14.2% | +2.7% | 3↑ 0↓ | $6.6B | 3.6% | 2 |
| Next FY 2027-12-31 |
$1.32 | $1.10 | $1.62 | -0.4% | +0.0% | 3↑ 0↓ | $6.9B | 4.6% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.258 | |
| 7d ago | $0.258 | |
| 30d ago | $0.258 | |
| 60d ago | $0.347 | -0.089 |
| 90d ago | $0.357 | -0.100 |
5 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 7, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 10, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Mar 6, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Jan 20, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Dec 18, 2025 | UBS | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | Mizuho | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 7 | 5 | 1 | 0 | 67% | |
| May 1, 2026 | 5 | 7 | 5 | 1 | 0 | 67% | |
| Apr 1, 2026 | 5 | 8 | 5 | 1 | 0 | 68% | |
| Mar 1, 2026 | 5 | 8 | 5 | 1 | 0 | 68% | |
| Feb 1, 2026 | 5 | 8 | 5 | 1 | 0 | 68% | |
| Jan 1, 2026 | 5 | 8 | 5 | 1 | 0 | 68% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 5, 2026
earnings_calendar
ARDT Q1 2026 Earnings Scheduled — 2026-05-05
Mar 4, 2026
earnings_calendar
ARDT Q4 2025 Earnings Scheduled — 2026-03-04